AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
7,735.00+55.00 (+0.72%)
At close: 4:39PM BST
Loading interactive chart…
- Editor's pickYahoo Finance Video
Pfizer begins process of seeking full U.S. vaccine approval: RPT
Yahoo Finance’s Anjalee Khemlani reports the latest developments on the coronavirus vaccines.
- Business Wire
IMFINZI and tremelimumab With Chemotherapy Demonstrated Overall Survival Benefit in POSEIDON Trial for 1st-line Stage IV Non-small Cell Lung Cancer
POSEIDON was a Phase III trial of AstraZeneca’s IMFINZI® (durvalumab) plus platinum-based chemotherapy or IMFINZI, tremelimumab and chemotherapy versus chemotherapy alone in the 1st-line treatment of patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).
- Yahoo Finance Video
India's COVID-19 cases soar with over 412,000 confirmed
Dr. Oni Blackstock, Health Justice Founder & Executive Director, joined Yahoo Finance to discuss the latest on covid-19.
© 2021 Verizon Media. All rights reserved.
